共 50 条
- [21] Phase I trial of BMS-247550 and gemcitabine in patients with advanced solid tumor malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 151S - 151SAnderson, S论文数: 0 引用数: 0 h-index: 0机构: MSKCC, New York, NY USA MSKCC, New York, NY USADizon, D论文数: 0 引用数: 0 h-index: 0机构: MSKCC, New York, NY USA MSKCC, New York, NY USASabbatini, P论文数: 0 引用数: 0 h-index: 0机构: MSKCC, New York, NY USA MSKCC, New York, NY USADupont, J论文数: 0 引用数: 0 h-index: 0机构: MSKCC, New York, NY USA MSKCC, New York, NY USAPezzulli, S论文数: 0 引用数: 0 h-index: 0机构: MSKCC, New York, NY USA MSKCC, New York, NY USAMassey, A论文数: 0 引用数: 0 h-index: 0机构: MSKCC, New York, NY USA MSKCC, New York, NY USAAghajanian, C论文数: 0 引用数: 0 h-index: 0机构: MSKCC, New York, NY USA MSKCC, New York, NY USA
- [22] Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial resultsCELL REPORTS MEDICINE, 2023, 4 (02)论文数: 引用数: h-index:机构:Park, Robin论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Div Hematol & Med Oncol, Tampa, FL 33612 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USADai, Junqiang论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ, Dept Biostat, Med Ctr, Kansas City, KS 66160 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USAAl Rjabi, Raed论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USA Kansas Univ Canc Ctr, Kansas City, KS 66205 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USAKasi, Anup论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USA Kansas Univ Canc Ctr, Kansas City, KS 66205 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USABaranda, Joaquin论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USA Kansas Univ Canc Ctr, Kansas City, KS 66205 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USAWillamson, Stephen论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USA Kansas Univ Canc Ctr, Kansas City, KS 66205 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USASaeed, Azhar论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USARipp, Jacob论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USACollins, Zachary论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ, Dept Radiol, Med Ctr, Kansas City, KS 66160 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USAMulvaney, Kelly论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ Canc Ctr, Kansas City, KS 66205 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USAShugrue, Molly论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ Canc Ctr, Kansas City, KS 66205 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USAFirth-Braun, Jeanette论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ Canc Ctr, Kansas City, KS 66205 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USAK. Godwin, Andrew论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ Canc Ctr, Kansas City, KS 66205 USA Kansas Univ, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USAMadan, Rashna论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USAPhadnis, Milind论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ, Dept Biostat, Med Ctr, Kansas City, KS 66160 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USASun, Weijing论文数: 0 引用数: 0 h-index: 0机构: Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USA Kansas Univ Canc Ctr, Kansas City, KS 66205 USA Kansas Univ, Dept Med, Div Med Oncol, Med Ctr, Kansas City, KS 66160 USA
- [23] Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal TumorsCLINICAL CANCER RESEARCH, 2022, 28 (08) : 1507 - 1517Chi, Ping论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAQin, Li-Xuan论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USACamacho, Niedzica论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAKelly, Ciara M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAD'Angelo, Sandra P.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USADickson, Mark A.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAGounder, Mrinal M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAKeohan, Mary L.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAMovva, Sujana论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USANacev, Benjamin A.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USARosenbaum, Evan论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAThornton, Katherine A.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USACrago, Aimee M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Surg, New York, NY USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAFrancis, Jasmine H.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAMartindale, Moriah论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAPhelan, Haley T.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USABiniakewitz, Matthew D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USALee, Cindy J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USASinger, Samuel论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Surg, New York, NY USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAHwang, Sinchun论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USABerger, Michael F.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAChen, Yu论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USAAntonescu, Cristina R.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USATap, William D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA
- [24] Phase I trial of gemcitabine and epirubicin in patients with solid malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 360S - 360SMahadevan, D论文数: 0 引用数: 0 h-index: 0机构: Arizona Canc Ctr, Tucson, AZ USADreisbach, L论文数: 0 引用数: 0 h-index: 0机构: Arizona Canc Ctr, Tucson, AZ USAWilliams, D论文数: 0 引用数: 0 h-index: 0机构: Arizona Canc Ctr, Tucson, AZ USAPilkington, D论文数: 0 引用数: 0 h-index: 0机构: Arizona Canc Ctr, Tucson, AZ USAGebremarium, C论文数: 0 引用数: 0 h-index: 0机构: Arizona Canc Ctr, Tucson, AZ USAMartin, E论文数: 0 引用数: 0 h-index: 0机构: Arizona Canc Ctr, Tucson, AZ USAObregon, Y论文数: 0 引用数: 0 h-index: 0机构: Arizona Canc Ctr, Tucson, AZ USAVon Hoff, D论文数: 0 引用数: 0 h-index: 0机构: Arizona Canc Ctr, Tucson, AZ USA
- [25] Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)Taylor, Matthew H.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAVogelzang, Nicholas J.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USACohn, Allen Lee论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAStepan, Daniel E.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAShumaker, Robert Charles论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USADutcus, Corina E.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USAGuo, Matthew论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USASchmidt, Emmett V.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USARasco, Drew W.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USA
- [26] Phase I trial of sequential azacitidine and valproic acid plus carboplatin in the treatment of patients with advanced malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)Bustinza-Linares, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAFalchook, G. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAFu, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USANaing, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAHong, D. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAHu, W.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAMoulder, S. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAWheler, J. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USASood, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKurzrock, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
- [27] A phase II trial of modified triple doublets for the treatment of advanced Mullerian malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 457S - 457SMatulonis, UA论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USACampos, S论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAKrasner, C论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USADuska, L论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAPenson, RP论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAFalke, R论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USARoche, M论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USASmith, LM论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USALee, H论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USASeiden, MV论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA
- [28] A phase I trial of the mTOR inhibitor temsirolimus (TEM) in combination with capecitabine (CAP) in patients with advanced malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Pishvaian, Michael J.论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USAWang, Hongkun论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USAHardesty, Rosemarie A.论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USADeeken, John F.论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USAHe, Aiwu Ruth论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USASubramaniam, Deepa Suresh论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USAZhuang, Tingting论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USAMcCarthy, Damian L.论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USAMelville, Heather论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USAAlbanese, Christopher论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA论文数: 引用数: h-index:机构:Hwang, Jimmy J.论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
- [29] Phase Ib trial of bryostatin 1 in patients with refractory malignanciesCLINICAL CANCER RESEARCH, 1998, 4 (03) : 611 - 618Grant, S论文数: 0 引用数: 0 h-index: 0机构: Virginia Commonwealth Univ, Med Coll Virginia, Div Hematol Oncol, Massey Canc Ctr,Dept Med, Richmond, VA 23298 USARoberts, J论文数: 0 引用数: 0 h-index: 0机构: Virginia Commonwealth Univ, Med Coll Virginia, Div Hematol Oncol, Massey Canc Ctr,Dept Med, Richmond, VA 23298 USAPoplin, E论文数: 0 引用数: 0 h-index: 0机构: Virginia Commonwealth Univ, Med Coll Virginia, Div Hematol Oncol, Massey Canc Ctr,Dept Med, Richmond, VA 23298 USATombes, MB论文数: 0 引用数: 0 h-index: 0机构: Virginia Commonwealth Univ, Med Coll Virginia, Div Hematol Oncol, Massey Canc Ctr,Dept Med, Richmond, VA 23298 USAKyle, B论文数: 0 引用数: 0 h-index: 0机构: Virginia Commonwealth Univ, Med Coll Virginia, Div Hematol Oncol, Massey Canc Ctr,Dept Med, Richmond, VA 23298 USAWelch, D论文数: 0 引用数: 0 h-index: 0机构: Virginia Commonwealth Univ, Med Coll Virginia, Div Hematol Oncol, Massey Canc Ctr,Dept Med, Richmond, VA 23298 USACarr, M论文数: 0 引用数: 0 h-index: 0机构: Virginia Commonwealth Univ, Med Coll Virginia, Div Hematol Oncol, Massey Canc Ctr,Dept Med, Richmond, VA 23298 USABear, HD论文数: 0 引用数: 0 h-index: 0机构: Virginia Commonwealth Univ, Med Coll Virginia, Div Hematol Oncol, Massey Canc Ctr,Dept Med, Richmond, VA 23298 USA
- [30] A phase I study of sirolimus (rapamycin) and bevacizumab in patients with advanced malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)Cohen, E. E.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Med Ctr, Chicago, IL 60637 USASharma, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Med Ctr, Chicago, IL 60637 USAJanisch, L. A.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Med Ctr, Chicago, IL 60637 USAStadler, W. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Med Ctr, Chicago, IL 60637 USAKang, S. P.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Med Ctr, Chicago, IL 60637 USAFleming, G. F.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Med Ctr, Chicago, IL 60637 USARatain, M. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Med Ctr, Chicago, IL 60637 USA